Evidence map›Paper›PMID 40135944›Full record

ReviewFuture microbiology2025

Multidrug-resistant hypervirulent

Yu Zheng, Xiaojue Zhu, Chao Ding, Weiqiang Chu, Xiaoxiao Pang, Ruxia Zhang, Jiucheng Ma, Guoxin Xu

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Future microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Hypervirulent and Drug-ResistantInternational journal of general medicine · 2026
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yu ZhengDepartment of Clinical Laboratory, The Affiliated Zhangjiagang Hospital of Soochow University, Suzhou, China.
Xiaojue ZhuDepartment of Clinical Laboratory, The Affiliated Zhangjiagang Hospital of Soochow University, Suzhou, China.
Chao DingDepartment of Clinical Laboratory, The Affiliated Zhangjiagang Hospital of Soochow University, Suzhou, China.
Weiqiang ChuDepartment of Clinical Laboratory, The Affiliated Zhangjiagang Hospital of Soochow University, Suzhou, China.
Xiaoxiao PangDepartment of Clinical Laboratory, The Affiliated Zhangjiagang Hospital of Soochow University, Suzhou, China.
Ruxia ZhangDepartment of Clinical Laboratory, The Affiliated Zhangjiagang Hospital of Soochow University, Suzhou, China.
Jiucheng MaDepartment of Burns and Plastic Surgery, The Affiliated Zhangjiagang Hospital of Soochow University, Suzhou, China.
Guoxin XuDepartment of Clinical Laboratory, The Affiliated Zhangjiagang Hospital of Soochow University, Suzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multidrug-resistant hypervirulent

Indexed as

Drug Resistance, Multiple, BacterialKlebsiella InfectionsKlebsiella pneumoniaeAnti-Bacterial AgentsAsiaBacterial ProteinsChinaHumansVirulenceVirulence FactorsAnti-Bacterial AgentsBacterial ProteinsVirulence Factorsdiagnostic microbiologyhorizontal gene transferKlebsiella pneumoniaemultidrug resistancevirulence factor

Identifiers

PMID40135944
PMCPMC11980460

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.